Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8327754

CNC1(Cc2nc3ccccc3[nH]2)N=c2ccccc2=N1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 1/20 0.48
CHRM1 P11229 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
PKM P14618 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
GAA P10253 1/20 0.42
PIN1 Q13526 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
DDAH1 O94760 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6950609 0.78 PKM (0.71) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL8325860 0.76 CHRM1 (0.58) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL31621378 0.70 SMN1; SMN2 (0.52) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2
SCHEMBL10946704 0.68 CYP1A2 (0.74) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL5659985 0.68 FAAH (0.49) CYP1A2CYP2C9CHRM1SMN1; SMN2KDM4E
Trifluoroacetic Acid SCHEMBL3717753 0.67 ALDH1A1 (0.68) CYP1A2CYP2C9CHRM1SMN1; SMN2KDM4E
Trifluoroacetic Acid SCHEMBL9007642 0.66 POLB (0.47) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL8515964 0.66 SMN1; SMN2 (0.58) CHRM1TDP1SMN1; SMN2KDM4EALDH1A1
SCHEMBL12409534 0.66 ALDH1A1 (0.67) CHRM1TDP1SMN1; SMN2KDM4EHSD17B10
Trifluoroacetic Acid SCHEMBL8515314 0.66 CHRM1 (0.48) CYP1A2CYP2C9CHRM1TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869787-A4 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 1999-03-24 EP disclosed
EP-0869787-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1998-10-14 EP disclosed
WO-1997024119-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1997-07-10 WO disclosed